AzTrials
AzTrials

DementiaNCT02747745

Theoretical Based Case Management Intervention for Dementia Family Caregivers

A study testing Four risk areas reflecting the great needs of FCGs of PWDs in people with Dementia, run by Chang Gung University at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The growing number of persons with dementia (PWDs) calls for policy changes and service innovation. Recent case management (CM) research is recognized by its positive impacts on family caregivers (FCGs) of PWDs. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dementia
What is being tested?
Four risk areas reflecting the great needs of FCGs of PWDs
Could I receive a placebo?
No, everyone receives an active treatment
How many people
152 participants
Where
1 siteTaiwan
Study dates
Jan 2016to Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age being older than 60 years old;
  • having a primary FCG or a secondary FCG who can provides sufficient information and assistant for the PWD; co-residence is not required;
  • PWDs are those with cognitive impairment confirmed by the primary or secondary FCG or participating neurologists

Who cannot join

  • acute illnesses, impaired sensory symptoms (hearing loss and severe visual problems);
  • acute agitation which requires emergency treatment;
  • chronic alcohol abuse or use of drugs which possibly affect central nervous system functions;
  • presence of major psychiatric disorders within the last 2 years;
  • neurological or systemic illness (e.g. delirium, hypoxia, or unstable thyroid dysfunction);
  • no primary FCG or secondary FCG.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site, 1 recruiting
  • Catholic Mercy Hospital

    Hukou, Hsinchu, 303

    Jung-Lung Hsu, PhD., 886-3-3281200 ext. 8950, tulu@ms36.hinet.net

    Recruiting

Other trials in Taiwan

About this study

The growing number of persons with dementia (PWDs) calls for policy changes and service innovation. Recent case management (CM) research is recognized by its positive impacts on family caregivers (FCGs) of PWDs. However, research gaps are identified, including the paucity of theoretical based CM practice and a lack of mediator effects. Therefore, the original purpose of this five-year project was to implement a theoretical-based randomized controlled CM intervention for FCGs of early to moderate PWDs at home based on a stress model and tailor to needs prioritized by FCGs. This project was funded by the Minister of Scientific and Technology for the first two years and accomplished the first two aims: 1. First year: to develop and test the psychometric properties of related instruments and protocol (cross-sectional study); 2. Second year: to conduct a feasibility test for the CM intervention (a pilot RCT). The purpose of the current project is to achieve aim 3 (three years): to implement a 4-month CM intervention (the main RCT). In total, there will be 2 home visits, 2 phone calls to the dyads, and receiving telephone calls from the FCGs during the working hours. Investigator will collect 4-time point data at T0 for base line data, T1 (after the recruitment, 4 th month, the first follow up), T2 (after the recruitment, 6th month, the second follow up) and T3 (after the recruitment,12 th month). Investigator will recruit 76 dyads in three years (38 dyads for each group)(n = 152 in total). The primary outcomes are FCG QoL and PWD behavioral problems, while the secondary outcome is the percentages of PWD status (i.g. nursing home admission) and the frequency of PWD acute hospitalization. Investigator will also test of mediator effect of FCG self efficacy using statistical analysis method such as Hierarchical Linear Modeling (HLM).

Read the detailed description

The primary care physicians in the memory disorder clinics at the participating hospitals (Chang-Gung Memorial Hospital at Lin-Kuo, Chang-Gung Memorial Hospital-Taoyuan branch, Catholic Mercy Hospital at Hukou, Hsinchu county) will receive a written letter to explain the purpose of this project and the eligible criteria of PWDs and their FCGs. Debriefing can be provided upon request. Then the participating physicians will help to identify eligible dyads; while one trained research assistant (RA) is responsible for CM implementation (RA I), and the second RA (graduate students, RA II) will be responsible for data collection in each time point.

To increase the feasibility of this project, the inclusion criteria of PWDs are made to reflect the recruiting site reality, including: (1) age being older than 60 years old; (2) having a primary FCG or a secondary FCG who can provides sufficient information and assistant for the PWD; co-residence is not required; (3) PWDs are those with cognitive impairment confirmed by the primary or secondary FCG or participating neurologists. The exclusion criteria of PWDs include: (1) acute illnesses, impaired sensory symptoms (hearing loss and severe visual problems); (2) acute agitation which requires emergency treatment; (3) chronic alcohol abuse or use of drugs which possibly affect central nervous system functions; (4) presence of major psychiatric disorders within the last 2 years; (5) neurological or systemic illness (e.g. delirium, hypoxia, or unstable thyroid dysfunction); (6) no primary FCG or secondary FCG.

Investigator will screen for FCGs who report and meet the criteria of moderate levels of severity in the following risk areas (Table 1): depressive symptoms, burden, distress to problematic behaviors of PWDs and healthy behaviors. The definition of primary FCG include: (1) age 18 years old or greater; (2) at least providing the most assistance (4 hours a day) to their relatives with dementia for the past three months or those who conduct secondary care to their relatives, meaning that these FCGs supervise the hired care assistants or foreign helpers who actually take care of the patients; co-residency is not required for family caregivers. Exclusion criteria of family caregivers include: (1) documented cognitive or mental disorder, such as severe memory problems or major affective disorders; (2) hearing or visual impairments which are not properly corrected; (3) prescribed drugs known to impair or enhance attention, e.g., antidepressants, barbiturates, or other depressants, amphetamines; (4) insufficient command of Mandarin, Taiwanese; (5) participation in other interventions which may contaminate the results of this study.

In previous project, the satisfactory level of our case management training course was high. All the trainees had the highest regard toward the professional quality of the content and the instructors (Chiu et al, 2013). One of the case managers served as research assistant in the previous project and will continue to work with us as interventionist upon funded. Investigator will conduct a three-year RCT involving repeated measures at four time points: baseline screening (T0), 4th month (the end of the intervention, T1), 6th month (post-treatment follow up, T2), 12th month (T3).

Randomization Randomization takes place after baseline assessment. An external independent person establishes the random order using random number tables.

CM Intervention Protocol The 4-month CM intervention on FCGs of PWDs involves 2 home visits, 2 phone calls from the case manager to the dyads, and receiving telephone calls from FCGs during the working hours (Monday through Friday, 9-5). The case manager will target the prioritized risk from the 4 risk areas of FCG problems: depressive symptoms, burden, distress to problematic behaviors of PWDs, and healthy behaviors (Table 1). The intervention mainly consists of 1. needs assessment and nursing education on home environment modification and safety, behavioral management and communication skills(Belle et al., 2006); 2. home-based cognitive stimulation on PWD with simple mathematical practice (Cheng et al., 2013), patient preferred leisure activities (Chiu et al., 2015) and reminiscence by old time photos, stories and toys (Chiu et al., 2013); 3. brief consultation on 4 risk areas related to FCG stress (Belle et al., 2006) and 4. case management to refer the dyads to the hospital-based dementia centers and community resources (Chien et al., 2010). The case manager will assess the recruited dyads at the beginning of the intervention (T0), develop a tailored care plan based on the prioritized risk area of the FCGs and conduct the first home visit in the 1st month to build up a partnership with FCGs, discuss the care plan with the FCGs (and PWDs if possible). Each risk area of each FCG will be dealt with CM components such as education, brief counseling, problem solving and evidence based strategies derived from the Pearlin's theoretical principles. The case manager will teach the FCGs how to implement the home-based cognitive stimulation and cognitive training for PWDs and provide them the daily log for recording these activities and any leisure-time physical activities as well as medical cost. There will be two telephone calls in the 2nd and 3rd months to reinforce the dyads about the taught strategies, collect the log data and remind them the date of the next home visit (4th month). If the problems in each risk area persist until the first phone call, the case manager will discuss this case in a multidisciplinary conference in the participating dementia centers with nurses, social workers, clinical psychologists and neurologists. Then a revised care plan will be developed and additional home visit will be conducted in the 3rd month. If it is necessary, the case manager will refer the dyads to the hospital-based dementia centers, memory clinics or governmental resources. The frequent contacts are to ensure the CM strategies can reflect the changing needs of the FCGs. The definition of compliance is 80% of CM strategies completed by the dyads. The outcome data will be collected after the recruitment in the 4th month (T1), 6th month (T2) and 12th moth (T3) either by home visits or dementia center or memory clinic visits.

To ensure the quality of medical care, both group participants will be followed up at three monthly intervals in the dementia centers. PWDs of the experimental and control groups will receive standard medical treatment as clinically indicated.

For the control group, after the initial assessment, the case manager will give the dyads written information about dementia and its progress as well as home safety during the first home visit. Then case manager will make 2 phone calls in the 2nd and 3rt months for social interactions with the control group and collect the cost data. These phone calls do not involve in active education, consultation or cognitive stimulation and training. The control dyads will remain their usual care, i.e., visiting their primary care physicians or special neurologists for treatments or related consultation as well as education. The participating physicians will be unaware of the dyads allocation to either intervention or control condition. The dyads in the control group have no access to most of the structured and tailored activities. The outcome data will be collected at the 4th month (T1), 6th month (T2) and 12th month (T3)

Conditions
Dementia
Being tested
Four risk areas reflecting the great needs of FCGs of PWDs
Keywords
Caregivers, Case Management, Community Dwelling
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Four risk areas reflecting the great needs of FCGs of PWDsBehavioural

    The intervention involves home visits \& phone calls from the case manager to the dyads, and receiving telephone calls from FCGs. The case manager will target the prioritized risk from the 4 risk areas of FCG problems and healthy behaviors. The intervention mainly consists of needs assessment and nursing education on home environment modification and safety, behavioral management and communication skills; home-based cognitive stimulation on PWD with simple mathematical practice, patient preferred leisure activities and reminiscence by old time photos, stories and toys; brief consultation on 4 risk areas related to FCG stress; and case management to refer the dyads to the hospital-based dementia centers and community resources.

Study groups in NCT02747745
Study groupRoleWhat they receive
Control GroupNo interventionGroup receive no intervention
Interventional GroupExperimentalFour risk areas reflecting the great needs of FCGs of PWDs: depressive symptoms, burden, distress to problematic behaviors of PWDs and healthy behaviors.
Receives: Behavioral: Four risk areas reflecting the great needs of FCGs of PWDs

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Change of FCG Quality of Life

    The FCG QoL will be measured by the composite score of the measures from the 4 risk areas of FCGs for PWDs using The Center for Epidemiologic Depression (CESD-10), Chinese Caregiving Burden Scale (CBS), Neuropsychological Inventory (NPI) caregiver distress scale, and Health Promotion Profile.

    Measured: The outcome data will be collected after the recruitment in the 4th month (T1), 6th month (T2) and 12th moth (T3) either by home visits or dementia center or memory clinic visits.

Secondary outcomes (1)
  1. Yielding to FCG role (the PWD status)

    The secondary outcome of the CM intervention is yielding to FCG role based on PWD status: staying at home, admitting to hospital and admitting to nursing home. The time of events and days of staying will be collected through FCGs.

    Measured: The outcome data will be collected after the recruitment in the 4th month (T1), 6th month (T2) and 12th moth (T3) either by home visits or dementia center or memory clinic visits.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Apr 2016 (estimated)
  2. Study startJan 2016
  3. Primary completionDec 2018 (estimated)
  4. Study completionDec 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Participant
Enrolment
152 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02747745
Sponsor's protocol ID
CMRPD1F0051
Other IDs
CMRPD1F0051
Status last verified
Apr 2016
First submitted
10 Apr 2016
Last updated
22 Apr 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Four risk areas reflecting the great needs of FCGs of PWDs in people with Dementia, run by Chang Gung University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yi-Chen Chiu, PhD. (886-3-211-8800 ext. 5148, yulandac@mail.cgu.edu.tw, lab.yulandac@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Change of FCG Quality of Life (time frame: The outcome data will be collected after the recruitment in the 4th month (T1), 6th month (T2) and 12th moth (T3) either by home visits or dementia center or memory clinic visits.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in